[1] Baldwin J E, Crouch N P, Fujishima Y, et al. 4Hydroxyphenylpyruvate dioxygenase appears to display aketoisocaproate dioxygenase activity in ratliver. Bioorg Med Chem Lett,1995, 5(8):12551260.
[2] Ruetschi U, Cerone R, PerezCerda C, et al.Mutations in the 4hydroxyphenylpyruvate dioxygenase gene (HPD) in patients with tyrosinemia typeIII, Hum Genet, 2000,106:654662.
[3] Graham R Moran. 4hydroxyphenylpyruvate dioxygenase. Archives of Biochemistry and Biophysics,2005,433 (11):117128.
[4] Corinne R, Matthieu G, Yohann M, et al. 4hydroxyphenylpyruvate dioxygenase catalysis. The Journal of Biological Chemistry, 2011,286(7):26061–26070.
[5] Shah D D, Conrad J A, Heinz B, et al. Evidence for the mechanism of hydroxylation by 4hydroxyphenylpyruvatedioxygenase and hydroxymandelate synthase from intermediate partitioning in active site variants. Biochemistry,2011, 50(5):76947704.
[6] Yasuhiko T, Kimitoshi N, Shirou M, et al.Gene expression prowles of homogentisatetreated Fah/Hpd/mice using DNA microarrays. Molecular Genetics and Metabolism,2006,89(8):203209.
[7] Wang J, Huo K K, Ma L X, et al. Toward an understanding of the protein interaction network of the human liver. Molecular Systems Biology,2011,536(11):17444292.
[8] 于海涛.肝细胞核因子HNF1α调控Hepassocin启动子活性的研究.北京:中国人民解放军军事医学科学院放射与辐射医学研究所,2008.
Yu H T.The Research on the Promoter Activity of the Hepassocin gene Regulated by HNF1α.Beijing:Institute of Radiation Medicine,Academy of Military Medical Science,2008.
[9] Miyajima A, Furihata T, Chiba K.Functional analysis of GC Box and its CpG methylation in the regulation of CYP1A2 gene expression. Drug Metab Pharmacokinet, 2009,24(3):269276.
[10] Hoppe K L, Francone O L.Binding and functional effects of transcription factors Sp1 and Sp3 on the proximal human lecithin:cholesterol acyltransferase promoter. J Lipid Res,1998,39(5):969977.
[11] Kumari S, Saradhi M, Rana M, et al. Pregnane and xenobiotic receptor gene expression in liver cells is modulated by Ets1 in synchrony with transcription factors Pax5, LEF1 and cjun. Exp Cell Res,2015,330(2):398411.
[12] 侯琳, 钱敏平, 朱云平,等. 转录因子结合位点生物信息学研究进展. Hereditas,2009, 31(4): 365373.
Hou L, Qian M P, Zhu Y P, et al. Advances on bioinformatic research in transcription factor binding sites. Hereditas, 2009, 31 (4): 365373.
[13] 齐安东, 张杰, 李磊,等.HNF1α在肝癌组织中的表达及意义. 山东医药,2009,49(3):9697.
Qi A D, Zhang J, Li L, et al.The expression and significance of HNF1 alpha in hepatocellular carcinoma tissue. Shandong Medical Journal, 2009,49 (3): 9697.
[14] 龙云,唐红,刘聪,等.肝细胞核因子4α和3β在人主要器官中的表达. 世界华人消化杂,2006,14(25): 25042509.
Long Y, Tang H, Liu C, et al.Expression of hepatocyte nuclear factor 4α and 3βin human tissues. World Chinese Journal for Digestion, 2006,14 (25): 25042509.
[15] Chiang T S, Yang K C, Chiou L L, et al. Enhancement of CYP3A4 activity in He PG2 cells by lentiviral transfection of hepatocyte nuclear factor1alpha. Plos One,2014,9(4):9488594895.
[16] Taro E A, Frank J G. Regulation of P450 genes by liverenriched transcription factors and nuclear receptors. Biochimica et Biophysica Acta, 2003,1619(30):223234.
[17] MartínezJiménez C P, Castell J V, GómezLechón M J, et al.Transcriptional activation of CYP2C9, CYP1A1, and CYP1A2 by hepatocyte nuclear factor 4alpha requires coactivators peroxisomal proliferator activated receptorgamma coactivator 1alpha and steroid receptor coactivator 1. Mol Pharmacol,2006,70(5):16811692.
[18] Aline D S, Helayne S F, Maristela M, et al. Okamotoa,hepatocyte nuclear factors 1α/4α and forkhead box A2 regulate the solute carrier 2A2 (Slc2a2) gene expression in the liver and kidney of diabetic rats. Life Sci,2013,93(22):805813.
[19] Pramfalk C, Melhuish T A, Wotton D, et al. TGinteracting factor 1 acts as a transcriptional repressor of sterol Oacyltransferase 2. J Lipid Res,2014,55(4):709717.
[20] Croniger C,Leahy P,Reshef L, et al. C/EB Pand the control of phosphoenolpyruvate carboxykinase gene transcription in the liver.J Biol Chem,1998, 273(48):3162931632.
[21] Dang S, Chen P, Zhang B, et al.Expression and methylation status of FOXP3 in human hepatocellular carcinoma. Chinese Journal of Hepatology,2014,22(8):616619.
[22] 王亚莉,唐红.肝脏特异性转录调控序列的研究进展.生物医学工程学杂志,2009,26(2):443447.
Wang L Y,Tang H.Progress of researches on liverspecific transcriptional regulatory sequence.Journal of Biomedical Engineering,2009,26(2):443447.
[23] 程纪华,冷希圣,彭吉润,等.甲胎蛋白启动子调控表达p53 基因的肝癌细胞靶向性基因治疗载体的研究.中华医学杂志,2000, 80(6):461463.
Cheng J H,Leng X S,Peng J R,et al.Construction of a hepatomatargeting vector of adenoassociated virus containing human afetoprotein promoter and wild p53 gene in gene therapy of liver cancer.Chinese Medical Journal,2000, 80(6):461463.
[24] 郝萍. 甲胎蛋白启动子调控DTA基因表达对肝癌细胞靶向治疗的实验研究.重庆:第三军医大学新桥医院肿瘤中心,2004.
Hao P.Gene Therapy for Hepatoma Cells Using Diphtheria ToxinA under the Control of Promoter of the Human afeto Portein Gene.Chongqing:Xinqiao Hospital Cancer Center,Third Military Medical University,2004.
[25] 孙强玲.HBV启动子调控的肝细胞高表达载体构建及抑癌作用研究.北京:中国人民解放军军事医学科学院放射与辐射医学研究所,2002.
Sun Q L.Construction of Hepatocyte High Expression System of Vectors Driven by HBV Gene Promoter and Study of Anticancer Effct.Beijing:Institute of Radiation Medicine,Academy of Military Medical Science,2002. |